Oromandibular dystonia: a serious side effect of capecitabine

BACKGROUND: Capecitabine has activity against several types of cancer. In 10-15% of patients treated with capecitabine, treatment is discontinued because of serious adverse reactions, mostly within the first weeks of treatment. CASE PRESENTATION: A 56 year-old female patient presented at the emergen...

Descripción completa

Detalles Bibliográficos
Autores principales: van Pelt-Sprangers, Melanie JM, Geijteman, Eric CT, Alsma, Jelmer, Boere, Ingrid A, Mathijssen, Ron HJ, Schuit, Stephanie CE
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4358849/
https://www.ncbi.nlm.nih.gov/pubmed/25850956
http://dx.doi.org/10.1186/s12885-015-1132-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4358849/
https://www.ncbi.nlm.nih.gov/pubmed/25850956
http://dx.doi.org/10.1186/s12885-015-1132-1

Ejemplares similares